Login / Signup

IgA nephropathy pathogenesis and therapy: Review & updates.

Elmukhtar HabasElrazi AliKhalifa FarfarMahdi ErrayesJamal AlfitoriEshrak HabasHafedh GhazouaniRaza AkbarFahim KhanAisha Al DabAbdel-Naser Elzouki
Published in: Medicine (2022)
IgAN has a heterogeneous pattern worldwide, making it difficult to understand its pathogenesis and treatment. Proteinuria is the best guide to follow up on the IgAN progression and treatment response. Steroids are the cornerstone of IgAN therapy; however, other immune-suppressive and immune-modulative agents are used with a variable response rate. Kidney transplantation is highly advisable for IgAN patients, although the recurrence rate is high. Finally, IgAN management requires collaborative work between patients and their treating physicians for safe long-term outcomes.
Keyphrases
  • end stage renal disease
  • kidney transplantation
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • primary care
  • peritoneal dialysis
  • prognostic factors
  • cell therapy
  • patient reported
  • combination therapy